P671: TREATMENT SEQUENCES AND OUTCOMES OF PATIENTS WITH CLL TREATED WITH TARGETED AGENTS IN REAL-WORLD SETTINGS

• A. R. Mato,
• B. S. Manzoor,
• C. C. Coombs,
• N. Lamanna,
• H. H. Tuncer,
• J. R. Brown,
• L. E. Roeker,
• M. Shadman,
• J. N. Allan,
• C. Ujjani,
• B. Eichhorst,
• L. Leslie,
• I. Fleury,
• H. Alhasani,
• J. Rhodes,
• B. T. Hill,
• P. M. Barr,
• A. Skarbnik,
• M. S. Davids,
• R. Bannerji,
• M. Fuldeore,
• F. Lansigan,
• A. Schuh,
• L. Pearson,
• C. P. Fox,
• I. Pivneva,
• L. Popadic,
• A. Guerin,
• T. A. Eyre

Affiliations

A. R. Mato

1 Memorial Sloan Kettering Cancer Center, New York

B. S. Manzoor

2 AbbVie, Inc., North Chicago

C. C. Coombs

3 Lineberger Comprehensive Cancer Center, Chapel Hill

N. Lamanna

4 Columbia University, New York

H. H. Tuncer

5 The Cancer Center at Lowell General Hospital, Lowell

J. R. Brown

6 Dana-Farber Cancer Institute, Boston

L. E. Roeker

1 Memorial Sloan Kettering Cancer Center, New York

M. Shadman

7 Fred Hutchinson Cancer Research Center, Seattle

J. N. Allan

8 Weill Cornell Medicine University Medical Center, New York, United States of America

C. Ujjani

7 Fred Hutchinson Cancer Research Center, Seattle

B. Eichhorst

9 University of Cologne, Cologne, Germany

L. Leslie

10 John Theurer Cancer Center, Hackensack, United States of America

I. Fleury

11 Hôpital Maisonneuve-Rosemont, Montreal, Canada

H. Alhasani

2 AbbVie, Inc., North Chicago

J. Rhodes

12 Northwell Health Cancer Institute, Lake Success

B. T. Hill

13 Cleveland Clinic, Cleveland

P. M. Barr

14 Wilmot Cancer Institute, Rochester

A. Skarbnik

15 Novant Health, Charlotte

M. S. Davids

6 Dana-Farber Cancer Institute, Boston

R. Bannerji

16 Rutgers Cancer Institute of New Jersey, New Brunswick

M. Fuldeore

2 AbbVie, Inc., North Chicago

F. Lansigan

17 Dartmouth-Hitchcock Medical Center, Lebanon, United States of America

A. Schuh

18 Churchill Hospital, Oxford, United Kingdom

L. Pearson

19 Tufts Medical Center, Boston, United States of America

C. P. Fox

20 Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

I. Pivneva

21 Analysis Group, Inc., Montreal, Canada

L. Popadic

22 Analysis Group, Inc., New York, United States of America

A. Guerin

21 Analysis Group, Inc., Montreal, Canada

T. A. Eyre

18 Churchill Hospital, Oxford, United Kingdom